GlassScriptPhysician profile
Michael Haven
NPI 1144836461
$1,084.17
in general payments reported to CMS, 2019-2025
18 companies · $278 in 2025
The $278 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $115 · 2023: $428 · 2024: $264 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $970.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $969.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $162.24 | 2024-2025 | Airsupra, Breztri |
| Pfizer INC. | $132.67 | 2023-2025 | |
| Exact Sciences Corporation | $109.40 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $99.00 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Xeris Pharmaceuticals, INC. | $97.55 | 2023-2025 | Keveyis, Gvoke Hypopen |
| Lilly USA, LLC | $94.04 | 2022-2023 | Mounjaro, Trulicity, Jardiance |
| Glaxosmithkline, LLC. | $73.45 | 2022-2024 | Trelegy Ellipta |
| Abbvie INC. | $68.24 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.07 | 2022 | |
| Astellas Pharma US INC | $43.47 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $30.23 | 2023 | |
| Boston Scientific Corporation | $22.36 | 2025 | General - Therapies |
| Antares Pharma, INC. | $20.98 | 2023 | Nocdurna, Tlando, Xyosted |
| Novartis Pharmaceuticals Corporation | $19.27 | 2023 | |
| Amgen INC. | $18.82 | 2025 | Otezla, Repatha |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $17.81 | 2023 | Spravato |
| Horizon Therapeutics Plc | $16.49 | 2023 | Krystexxa |
| Lucid Diagnostics INC. | $14.08 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Haven listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.